Dindin, Cerilo C.

HRN: 25-63-86  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2025
CEFTRIAXONE 1G (VIAL)
12/28/2025
01/04/2026
IV
2g
OD
CAP
Checking Initial Appropriateness 
12/28/2025
AZITHROMYCIN 500MG TABLET (TAB)
12/28/2025
01/02/2026
PO
500mg
OD
CAP
Checking Initial Appropriateness 
01/02/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/02/2026
01/02/2026
IV
4.5g
Loading Dose
Cap
Checking Final Appropriateness 
01/02/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/02/2026
01/09/2026
IV
2.25g
Q8
Cap
Checking Final Appropriateness 
01/10/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/10/2026
01/31/2026
IV
2.25g
Q8H
Shock Multifactorial
Checking Initial Appropriateness 
01/12/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
01/12/2026
01/18/2026
IV
750ng
Q8
Hospital Acquired Pneumonia
01/12/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
01/12/2026
01/18/2026
Q48
750
Q48
HAP
Waiting Final Action 
01/15/2026
TENOFOVIR DISOPROXIL FUMARATE 300MG TAB
01/15/2026
01/21/2026
PO
300 Mg
OD
Intraabdominal Infection , Liver Cirrhosis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: